Form 4: Proto Labs COO Executes Stock Option Exercise and Sale

Chief Operations Officer Michael R. Kenison exercised stock options and sold 200 shares of Proto Labs Inc. common stock.

Summary

• Michael R. Kenison, Chief Operations Officer of Proto Labs Inc., exercised options to acquire 200 shares of common stock.
• The shares were acquired at prices of $33.84 and $33.52 per share.
• Following the acquisition, the reporting person sold the 200 shares at a price of $70.00 per share.
• The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on August 15, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine, pre-planned executive transaction.

Positives

• The transaction was pre-planned under a Rule 10b5-1 plan, indicating a systematic approach to equity management rather than reactive selling.

Negatives

• The transaction results in a reduction of the officer's direct beneficial ownership of company stock.

Risks

• None identified; this is a routine disclosure of executive equity transactions.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that routine insider selling via 10b5-1 plans is standard practice for executives to manage personal liquidity and is generally not indicative of a change in company outlook.

Comparison to Industry Standards

• The use of 10b5-1 plans is a standard corporate governance practice to avoid potential insider trading concerns.
• The volume of shares sold (200) is immaterial relative to the total outstanding shares of Proto Labs.

Stakeholder Impact

• Minimal impact on shareholders as the transaction volume is negligible.

Next Steps

• No future actions or milestones mentioned.

Key Dates

Keywords

Proto Labs, PRLB, Insider Trading, Form 4, Executive Compensation, Stock Options